COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,224 Articles (22,733 medRxiv, 8,491 bioRxiv)

Most recent first Previous |  Page 269: Articles 2681-2690  | Next

Pandemic-Related Post-traumatic Stress Symptomatology in COVID-19 Patients with and without Post-COVID Conditions
Guinee, E. P., Raza, H., Ballard, E., Shaw, J. S., Liang, C. J., Sneller, M., Chung, J. Y.
10.1101/2024.01.21.24301574 — Posted: 2024-01-22
Interrogating Changes in COVID-19 Vaccine Intent During the National Vaccine Rollout in the Philippines
Caple, A., Dimaano, A., Sagolili, M. M., Uy, A. A., Aguirre, P., Alano, D., Baul, K. A., Camaya, G. S., Carlos, A. R., Ciriaco, B. J., Clavo, P. J. M., Cuyugan, D., Fermo, C. F. G., Lanete, P. J., La Torre, A. J., Loteyro, T., Lua, R. M., Manansala, N. G., Mosquito, R., Octaviano, A., Orfanel, A. E., Papa, A. E., Pascual, G. M., Peralta, M. N., Sale, A. J., Tendenilla, S. L., Trinidad, M. S. L., Trinidad, N. J., Verano, D. L., Austriaco, N.
10.1101/2024.01.20.24301539 — Posted: 2024-01-21
Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: the devil is in the details.
Beaudart, C., Douxfils, J., Musuamba, F., Dogne, J.-M.
10.1101/2024.01.18.24301464 — Posted: 2024-01-21
The Paradigm Shift: Reclassification of SARS-CoV-2 and Longitudinal Immune Responses in Japanese Healthcare Workers
Chano, T., Kita, H., Yamashita, T., Fujimura, H., Ikemoto, T.
10.1101/2024.01.18.24301513 — Posted: 2024-01-20
UPTAKE OF REPRODUCTIVE, MATERNAL AND NEWBORN HEALTH IN THE CONTEXT OF COVID-19 PANDEMIC IN KENYA
Cheptum, J. J., Muia, R., Ongeso, A., Omoni, G., Omuga, B., Wagoro, M.
10.1101/2024.01.18.24301357 — Posted: 2024-01-20
nf-core/airrflow: an adaptive immune receptor repertoire analysis workflow employing the Immcantation framework
Gabernet, G., Marquez, S., Bjornson, R., Peltzer, A., Meng, H., Aron, E., Lee, N. Y., Jensen, C., Ladd, D., Hanssen, F., Heumos, S., nf-core community, , Yaari, G., Kowarik, M. C., Nahnsen, S., Kleinstein, S. H.
10.1101/2024.01.18.576147 — Posted: 2024-01-20
Differential gene expression analysis of spatial transcriptomic experiments using spatial mixed models
Ospina, O. E., Soupir, A. C., Manjarres-Betancur, R., Gonzalez-Calderon, G., Yu, X., Fridley, B. L.
10.1101/2024.01.20.576348 — Posted: 2024-01-20
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Aparicio, C., Willis, Z. I., Nakamura, M. M., Wolf, J., Little, C., Maron, G. M., Sue, P. K., Anosike, B. I., Miller, C., Bio, L. L., Singh, P., James, S. H., Oliveira, C. R., PIDS Pediatric COVID-19 Therapies Task Force
10.1101/2024.01.17.24301452 — Posted: 2024-01-18
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines
Kalkeri, R., Zhu, M., Cloney-Clark, S., Plested, J. S., Parekh, A., Gorinson, D., Cai, R., Mahato, S., Ramanathan, P., Aurelia, L. C., John Selva, K., Marchese, A. M., Fries, L., Chung, A. W., Dunkle, L. M.
10.1101/2024.01.17.24301374 — Posted: 2024-01-18
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Jittamala, P., Boyd, S., Schilling, W. H. K., Watson, J. A., Ngamprasertchai, T., Siripoon, T., Luvira, V., Batty, E. M., Wongnak, P., Esper, L. M., Almeida, P. J., Cruz, C., Ascencao, F. R., Aguiar, R. S., Ghanchi, N. K., Callery, J. J., Singh, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Madmanee, W., Suwannasin, K., Promsongsil, A., Hanboonkunupakarn, B., Poovorawan, K., Potaporn, M., Srisubat, A., Loharjun, B., Taylor, W. R., Qamar, F. N., Kazi, A. M., Beg, M. A., Chommanam, D., Vidhamaly, S., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Dondorp, A. M., Day, N. P., Teixeira, M.
10.1101/2024.01.16.24301337 — Posted: 2024-01-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).